Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04469075 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04469075 · ClinicalTrials.gov record · last posted 2026-08-10

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

StatusActive, Not Recruiting
PhasePhase 2
Started2020-07-09
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The participants are being treated with Tumor Treating Fields (TTFields) for malignant glioma, and this type of treatment may cause skin-related side effects. This study will test whether using clindamycin and triamcinolone topical lotions can prevent skin-related side effects of TTFields.

Protocol amendment history 2 changes detected by DataLookout

2026-08-11
Primary completion pushed: 2026-07 → 2027-07
2026-08-11
Completion pushed: 2026-07 → 2027-07
Trial Details
NCT Number NCT04469075
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Glioblastoma, Recurrent Glioblastoma, Skin Toxicity
Enrollment 48 participants
Start Date 2020-07-09
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-10